Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCitigroup Inc Regulatory News (13PH)

  • There is currently no data for 13PH

Form 8.3 - offeree

7 Jun 2021 15:27

RNS Number : 0755B
Citigroup Inc
07 June 2021
Β 

Ap19

Β 

Β 

FORM 8.3

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 8.3Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANEL ACT,Β 1997,Β TAKEOVERΒ RULES,Β 2013

Β 

DEALINGSΒ BYΒ PERSONSΒ WITHΒ INTERESTSΒ INΒ RELEVANTΒ SECURITIESΒ REPRESENTINGΒ 1%Β ORΒ MORE

Β 

1. KEYΒ INFORMATION

Β 

Name of person dealing (Note 1)

Citigroup Inc.

Company dealt in

Willis Towers Watson plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

Β 04 June 2021

Β 

2. INTERESTSΒ ANDΒ SHORTΒ POSITIONS

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ (followingΒ dealing)Β inΒ theΒ classΒ ofΒ relevantΒ securityΒ dealtΒ inΒ (NoteΒ 3)

Β 

Long

Short

Β 

Number

Β 

(%)

Number

Β 

(%)

(1) Relevant securities

3,593,959 2.79%

930,713 0.72%

(2) Derivatives (other than options)

28,937 0.02%

36,368 0.03%

(3) Options and agreements to purchase/sell

Β 

Total

3,622,896 2.81%

967,081 0.75%

Β Β Β Β Β Β Β 

Β 

(b) InterestsΒ andΒ shortΒ positionsΒ inΒ relevantΒ securitiesΒ ofΒ theΒ company,Β otherΒ thanΒ theΒ classΒ dealtΒ inΒ (NoteΒ 3)

Class of relevant security:

Long

Short

Β 

Number

Β 

(%)

Number

Β 

(%)

(1) Relevant securities

Β 

Β 

Β 

(2) Derivatives (other than options)

Β 

Β 

Β 

(3) Options and agreements to purchase/sell

Β 

Β 

Total

Β 

Β 

Β Β Β Β Β Β Β 

Β 

Ap20

Β 

Β 

1. DEALINGSΒ (NoteΒ 4)

Β 

(a) PurchasesΒ andΒ sales

Β 

Β 

Purchase/sale

Β 

Number of relevant securities

Β 

Price per unit (USD)

Purchase

229,648

Β Highest 260.53 Lowest 258.67

Sale

100

Highest 259.73 Lowest 258.15

Β 

Β 

(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)

Β 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

Β 

Β 

Β 

Β 

Β 

Β 

(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities

Β 

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii) Exercising

Β 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

Β 

Β 

Β 

Β 

Β 

(d) OtherΒ dealingsΒ (includingΒ transactionsΒ inΒ respectΒ ofΒ newΒ securities)Β (NoteΒ 4)

Β 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Β 

Β 

Β 

Β 

Ap21

Β 

2. OTHERΒ INFORMATION

Β 

Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

Β 

Β 

Β 

FullΒ detailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understandingΒ betweenΒ theΒ personΒ disclosing andΒ anyΒ otherΒ personΒ relatingΒ toΒ theΒ votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option referredΒ toΒ onΒ thisΒ formΒ orΒ relatingΒ toΒ theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ orΒ disposalΒ ofΒ anyΒ relevantΒ securitiesΒ toΒ whichΒ anyΒ derivativeΒ referredΒ toΒ onΒ thisΒ formΒ isΒ referenced.Β IfΒ none,Β this shouldΒ beΒ stated.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

IsΒ aΒ SupplementalΒ FormΒ 8Β attached?Β (NoteΒ 9) Β NO

Β 

Date of disclosure

07 June 2021

Contact name

Damian Flanagan

Telephone number

+ 44 (0) 2890 409 676

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETUBUSRABUNRAR
Date   Source Headline
27th Apr 20266:09 pmRNSHolding(s) in Company
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
10th Mar 20263:48 pmRNSHolding(s) in Company
3rd Feb 20261:22 pmRNSHolding(s) in Company
14th Jan 202612:23 pmRNSForm 8.5 (EPT/NON-RI) - Rio Tinto plc (CBNA)
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
3rd Oct 20256:19 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
15th Sep 202512:00 pmRNSIQE plc: Holding(s) in Company
9th Sep 20253:30 pmRNSIQE plc: Holding(s) in Company
5th Sep 20254:00 pmRNSIQE plc: Holding(s) in Company
29th May 20255:30 pmRNSHolding(s) in Company
11th Apr 20257:00 amRNSHolding(s) in Company
30th Jan 20259:45 amRNSForm 8.5 (EPT/NON-RI) - CBNA
6th Nov 20249:49 amRNSForm 8.5 (EPT/NON-RI) - (CBNA -NY)
26th Sep 202411:30 amRNSForm 8 (DD) - CBNA New York
26th Sep 202411:28 amRNSForm 8 (DD) - CBNA New York
26th Sep 202411:20 amRNSForm 8 (DD) - CBNA New York
27th Jun 202410:14 amRNSForm 8.5 (EPT/NON-RI) - CBNA New York
15th May 20244:58 pmRNS1st Quarter Results
24th Apr 20248:23 amRNSForm 8.5 (EPT/NON-RI)
23rd Apr 20248:51 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 20248:54 amRNSForm 8.5 (EPT/NON-RI)
5th Apr 202410:28 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202311:32 amRNSForm 8 (DD) - [offeree]-CBNA
23rd Jul 20214:10 pmRNSForm 8.3 - offeree
22nd Jul 20215:25 pmRNSForm 8.3 - offeree
21st Jul 20213:01 pmRNSForm 8.3 - offeree
20th Jul 20213:49 pmRNSForm 8.3 -offeree
19th Jul 20213:44 pmRNSForm 8.3 - offeree
16th Jul 20212:39 pmRNSForm 8.3 - offeree
15th Jul 20212:38 pmRNSForm 8.3 - offeree
14th Jul 20212:29 pmRNSForm 8.3 - offeree
13th Jul 20213:03 pmRNSForm 8.3 - offeree
12th Jul 20212:12 pmRNSForm 8.3 - offeree
9th Jul 20213:55 pmRNSForm 8.3 - offeree
8th Jul 20214:10 pmRNSForm 8.3 - offeree
7th Jul 20214:47 pmRNSForm 8.3 - offeree
5th Jul 20212:48 pmRNSForm 8.3 - offeree
2nd Jul 20212:38 pmRNSForm 8.3 - offeree
1st Jul 20212:54 pmRNSForm 8.3 - offeree
30th Jun 20212:29 pmRNSForm 8.3 - offeree
29th Jun 20213:09 pmRNSForm 8.3 - offeree
28th Jun 20211:53 pmRNSForm 8.3 - offeree
25th Jun 20213:04 pmRNSForm 8.3 - offeree

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.